Skip to main content
Clinical Trials/ISRCTN12353191
ISRCTN12353191
Completed
未知

A pilot randomized double-blinded single-dose provocation study on the effect of niacin on pulmonary arterial pressure

Georgetown University Institutional Review Board0 sites49 target enrollmentApril 23, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Pulmonary hypertension
Sponsor
Georgetown University Institutional Review Board
Enrollment
49
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26590128 results

Registry
who.int
Start Date
April 23, 2015
End Date
June 12, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Georgetown University Institutional Review Board

Eligibility Criteria

Inclusion Criteria

  • 1\. Over the age of 18
  • 2\. Display a tricuspid regurgitation jet velocity over 2\.7 m/s on an inpatient echocardiogram during their current hospital stay

Exclusion Criteria

  • 1\. Inability to provide written informed consent
  • 2\. Known pulmonary vascular disease
  • 3\. Known intolerance to niacin or current treatment with niacin
  • 4\. Current treatment with a non\-steroidal anti\-inflammatory drug (NSAID)
  • 5\. Known liver disease (AST/ALT \> 3x the upper limit of normal)
  • 6\. Patients currently on ventilator support or using a bi\-level positive airway pressure (BiPAP) device

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinically important venous thromboembolism following lower extremity fractures: epidemiology and preventioIsolated below-knee fractures (tibia and/or fibula) requiring surgical repairInjury, Occupational Diseases, PoisoningFractures
ISRCTN23254458niversity of Toronto (Canada)700
Completed
Not Applicable
Supervised Walking In comparison to Fitness Training for back paiChronic low back painMusculoskeletal DiseasesDorsalgia
ISRCTN17592092Health Research Board (HRB) (Ireland)246
Completed
Phase 1
A phase I, double-blind, randomized study to evaluate the safety and immunogenicity of a new Meningococcal A Conjugate vaccine versus a Meningococcal Polysaccharide A+C reference vaccine and a Tetanus Toxoid control vaccine, given as single intramuscular injections in healthy adults from 18 to 35 years of age (India)Meningococcal diseaseInfections and Infestations
ISRCTN17662153Serum Institute of India Limited (SIIL) (Secondary Sponsor - Program for Appropriate Technology in Health [PATH], USA)72
Completed
Not Applicable
CALC trial: Aprepitant for the treatment of cough in lung cancerTopic: National Cancer Research NetworkSubtopic: Lung CancerDisease: Lung (small cell), Lung (non-small cell)CancerMalignant neoplasm of bronchus and lung
ISRCTN16200035Christie Hospital NHS Foundation Trust (UK)20
Completed
Phase 2
A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)
ISRCTN17181395Bioheart Inc. (USA)46